Expanding the horizons of cytoreductive surgery-hyperthermic intraperitoneal chemotherapy and liver resection for colorectal peritoneal and liver metastases
- PMID: 40529911
- PMCID: PMC12170024
- DOI: 10.21037/hbsn-2025-189
Expanding the horizons of cytoreductive surgery-hyperthermic intraperitoneal chemotherapy and liver resection for colorectal peritoneal and liver metastases
Keywords: Colorectal peritoneal and liver metastases; cytoreductive surgery (CRS); hyperthermic intraperitoneal chemotherapy (HIPEC); liver resection; peritoneal metastases (PM).
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-2025-189/coif). N.K. serves as an unpaid editorial board member of HepatoBiliary Surgery and Nutrition. The other author has no conflicts of interest to declare.
Comment on
-
Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy and Liver Resection is a Treatment Option for Patients With Peritoneal and Liver Metastases From Colorectal Cancer.Ann Surg. 2024 Nov 1;280(5):745-752. doi: 10.1097/SLA.0000000000006492. Epub 2024 Aug 26. Ann Surg. 2024. PMID: 39185557 Free PMC article.
Similar articles
-
Hepatectomy for metachronous colorectal liver metastases following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a report of three cases.World J Surg Oncol. 2019 Jun 13;17(1):99. doi: 10.1186/s12957-019-1646-0. World J Surg Oncol. 2019. PMID: 31196097 Free PMC article.
-
Outcomes of Stable Lung Colorectal Metastases on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.J Gastrointest Surg. 2022 Aug;26(8):1724-1731. doi: 10.1007/s11605-022-05390-1. Epub 2022 Jun 29. J Gastrointest Surg. 2022. PMID: 35768716
-
Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy and Liver Resection is a Treatment Option for Patients With Peritoneal and Liver Metastases From Colorectal Cancer.Ann Surg. 2024 Nov 1;280(5):745-752. doi: 10.1097/SLA.0000000000006492. Epub 2024 Aug 26. Ann Surg. 2024. PMID: 39185557 Free PMC article.
-
Synchronous Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis.Dis Colon Rectum. 2021 Jun 1;64(6):754-764. doi: 10.1097/DCR.0000000000002027. Dis Colon Rectum. 2021. PMID: 33742615
-
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases - The Hong Kong experience and literature review.Asian J Surg. 2021 Jan;44(1):221-228. doi: 10.1016/j.asjsur.2020.05.010. Epub 2020 Jun 27. Asian J Surg. 2021. PMID: 32605790 Review.
References
-
- Franko J, Shi Q, Meyers JP, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomized trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol 2016;17:1709-19. 10.1016/S1470-2045(16)30500-9 - DOI - PubMed
-
- Quénet F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal me metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 2021;22:256-66. 10.1016/S1470-2045(20)30599-4 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources